Subir material

Suba sus trabajos a SEDICI, para mejorar notoriamente su visibilidad e impacto

 

Mostrar el registro sencillo del ítem

dc.date.accessioned 2020-10-08T14:43:05Z
dc.date.available 2020-10-08T14:43:05Z
dc.date.issued 2015
dc.identifier.uri http://sedici.unlp.edu.ar/handle/10915/106488
dc.description.abstract Vanadium is a transition metal that, being ubiquitously distributed in soil, crude oil, water and air, also found roles in biological systems and is an essential element in most living beings. There are also several groups of organisms which accumulate vanadium, employing it in their biological processes. Vanadium being a biological relevant element, it is not surprising that many vanadium based therapeutic drugs have been proposed for the treatment of several types of diseases. Namely, vanadium compounds, in particular organic derivatives, have been proposed for the treatment of diabetes, of cancer and of diseases caused by parasites. In this work we review the medicinal applications proposed for vanadium compounds with particular emphasis on the more recent publications. In cells, partly due to the similarity of vanadate and phosphate, vanadium compounds activate numerous signaling pathways and transcription factors; this by itself potentiates application of vanadium-based therapeutics. Nevertheless, this non-specific bio-activity may also introduce several deleterious side effects as in addition, due to Fenton’s type reactions or of the reaction with atmospheric O2, VCs may also generate reactive oxygen species, thereby introducing oxidative stress with consequences presently not well evaluated, particularly for long-term administration of vanadium to humans. Notwithstanding, the potential of vanadium compounds to treat type 2 diabetes is still an open question and therapies using vanadium compounds for e.g. antitumor and anti-parasitic related diseases remain promising. en
dc.format.extent 24-48 es
dc.language en es
dc.subject Vanadium es
dc.subject Biological properties es
dc.subject Cancer therapy es
dc.subject Insulin-enhancing agents es
dc.subject Antiparasitic activity es
dc.title Vanadium compounds in medicine en
dc.type Articulo es
sedici.identifier.uri http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC7094629&blobtype=pdf es
sedici.identifier.other pmid:32226091 es
sedici.identifier.other pmcid:PMC7094629 es
sedici.identifier.other doi:10.1016/j.ccr.2014.12.002 es
sedici.identifier.issn 0010-8545 es
sedici.creator.person Pessoa, Joao Costa es
sedici.creator.person Etcheverry, Susana Beatriz es
sedici.creator.person Gambino, Dinorah es
sedici.subject.materias Química es
sedici.description.fulltext true es
mods.originInfo.place Centro de Química Inorgánica es
sedici.subtype Revision es
sedici.rights.license Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
sedici.rights.uri http://creativecommons.org/licenses/by-nc-sa/4.0/
sedici.description.peerReview peer-review es
sedici.relation.journalTitle Coordination Chemistry Reviews es
sedici.relation.journalVolumeAndIssue vol. 301-302 es


Descargar archivos

Este ítem aparece en la(s) siguiente(s) colección(ones)

Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) Excepto donde se diga explícitamente, este item se publica bajo la siguiente licencia Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)